Chison Medical Technologies Co., Ltd. (SHA:688358)

SHA:688358 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	455.81	468.7	480.89	375.69	394.91	329.02
Other Revenue	-	-	2.95	5.16	2.9	4.07
Revenue	455.81	468.7	483.84	380.84	397.81	333.09
Revenue Growth (YoY)	-0.76%	-3.13%	27.05%	-4.26%	19.43%	-9.92%
Cost of Revenue	186.4	192.38	208.34	160.6	178.89	139.21
Gross Profit	269.41	276.32	275.5	220.24	218.92	193.88
Selling, General & Admin	92.94	92.63	84.26	81.84	76.15	56.91
Research & Development	77.43	79.63	77.07	77.88	72.29	55.64
Other Operating Expenses	-10.01	-7.94	-3.43	-4.3	-2.49	-2.01
Operating Expenses	160.36	164.33	161.48	154.02	146.68	111.67
Operating Income	109.05	111.99	114.02	66.22	72.24	82.21
Interest Expense	-	-	-0.36	-0.11	-0.07	-
Interest & Investment Income	5.61	6.12	29.6	16.43	19.59	27.82
Currency Exchange Gain (Loss)	-	-	5.49	26.13	-6.02	-8.54
Other Non Operating Income (Expenses)	36.46	38.52	-0.38	-0.38	-0.37	-0.27
EBT Excluding Unusual Items	151.11	156.62	148.36	108.29	85.37	101.22
Gain (Loss) on Sale of Investments	-0.18	0.17	2.93	-1.37	0.43	-
Gain (Loss) on Sale of Assets	5.61	4.61	3.02	-0.5	30.26	0.01
Asset Writedown	-5.03	-4.56	-0.06	-0.51	-1.59	-
Other Unusual Items	-	-	7.94	9.22	10.08	10.28
Pretax Income	151.51	156.85	162.19	115.13	124.54	111.51
Income Tax Expense	14.93	16.34	15.71	9.29	12.07	11.88
Net Income	136.58	140.51	146.48	105.84	112.47	99.64
Net Income to Common	136.58	140.51	146.48	105.84	112.47	99.64
Net Income Growth	-2.10%	-4.08%	38.40%	-5.89%	12.88%	-5.23%
Shares Outstanding (Basic)	112	112	110	113	112	112
Shares Outstanding (Diluted)	112	112	110	113	112	112
Shares Change (YoY)	1.72%	1.25%	-2.19%	0.11%	0.79%	28.88%
EPS (Basic)	1.22	1.26	1.33	0.94	1.00	0.89
EPS (Diluted)	1.22	1.26	1.33	0.94	1.00	0.89
EPS Growth	-3.75%	-5.26%	41.49%	-6.00%	12.00%	-26.47%
Free Cash Flow	126.78	131.83	51.9	11.53	0.78	51.56
Free Cash Flow Per Share	1.13	1.18	0.47	0.10	0.01	0.46
Dividend Per Share	-	-	0.800	0.700	0.357	0.571
Dividend Growth	-	-	14.29%	96.02%	-37.50%	-20.01%
Gross Margin	59.11%	58.95%	56.94%	57.83%	55.03%	58.21%
Operating Margin	23.92%	23.89%	23.57%	17.39%	18.16%	24.68%
Profit Margin	29.96%	29.98%	30.28%	27.79%	28.27%	29.91%
Free Cash Flow Margin	27.82%	28.13%	10.73%	3.03%	0.19%	15.48%
EBITDA	120.92	123.71	125.14	78.3	81.53	90.4
EBITDA Margin	26.53%	26.39%	25.86%	20.56%	20.50%	27.14%
D&A For EBITDA	11.87	11.72	11.13	12.07	9.29	8.19
EBIT	109.05	111.99	114.02	66.22	72.24	82.21
EBIT Margin	23.92%	23.89%	23.57%	17.39%	18.16%	24.68%
Effective Tax Rate	9.86%	10.42%	9.69%	8.07%	9.69%	10.65%
Revenue as Reported	-	-	483.84	380.84	397.81	333.09
Advertising Expenses	-	-	3.38	2.64	4.1	4.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.